BDNF and early-onset autosomal dominant Alzheimer disease: Recent studies have shown that AChE inhibitors significantly increase levels of brain-derived neurotrophic factor (BDNF) in serum of Alzheimer’s disease patients and in mice after transient cerebral ischemia and reperfusion [27,28].